Search alternatives:
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
0 decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
0 decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
1081
-
1082
-
1083
HDAC inhibition by quisinostat synergizes with proteasome inhibition to decrease synovial sarcoma cell viability.
Published 2017“…<p>(A) In all synovial sarcoma cell lines, but not HEK293T controls, the addition of 0.005 μM of bortezomib results in a downshift of approximately a full log of quisinostat, decreasing the amount of drug required to achieve the same effect as the HDAC inhibitor alone. …”
-
1084
-
1085
Emodin decreases proteinuria and fibronectin secretion in diabetic rats.
Published 2014“…Emodin significantly represses fibronectin secretion in diabetic rats. Scale, 50 μm. *P<0.05 vs. control; **P<0.01 vs. control. <sup>§</sup>P<0.05 vs. …”
-
1086
-
1087
-
1088
-
1089
Rapamycin decreases phosphorylated mTOR following OGD.
Published 2013“…<p>Primary cortical neurons were subjected to 1 hour OGD and then treated with rapamycin (20 nM) or vehicle (0.01% EtOH) for 24 h. (A) Cells were immunostained with phospho-mTOR Ser-2448 (green), Hoechst (blue) and MAP-2 (red). …”
-
1090
-
1091
-
1092
-
1093
-
1094
Memory defects, decreased anxiety, and increased social interaction.
Published 2011“…(I) <i>Sema6A<sup>−/−</sup></i> mutants displayed an increase in number of anogenital sniffing (p<0.05) and decrease in walkover (p<0.01) episodes relative to controls. …”
-
1095
-
1096
-
1097
TNFα decreased Best-3 expression in endothelium.
Published 2014“…**P<0.01 vs. control group, n = 8.</p>…”
-
1098
-
1099
-
1100